Abstract
We examined the clinical usefulness and efficacy of hemodilutional autologous bloodtransfusion (HAT) in 10 patients in whom radical prostatectomy was performed. The patients were divided into two groups: Group A, composed of 5 cases without HAT and Group B, composed of 5 cases with HAT. No severe problem occurred in either group, except for anemia in Group B. HAT is useful for eldery patients in whom massive bleedingis expected.
